Supreme Court to Hear High-Stakes Abortion Pill Challenge with DOJ and ACLU Input

The ACLU, along with the Center for Reproductive Rights and The Lawyering Project, has cautioned the Supreme Court about lower court decisions in a case involving the abortion pill mifepristone, citing reliance on "patently unreliable witnesses" and "ideologically tainted junk science." The groups argue that the lower courts' acceptance of claims from anti-abortion rights medical associations and doctors is an outlier and have raised concerns about the credibility of witnesses and the use of flawed studies. The case, which involves the FDA's actions surrounding mifepristone, is set for arguments on March 26 and is expected to have a nationwide impact on access to the medication.